Abbott Laboratories buy JPMorgan Chase & Co.
Start price
20.04.23
/
50%
€101.24
Target price
20.04.24
€111.01
Performance (%)
-0.75%
End price
21.04.24
€100.48
Summary
This prediction ended on 21.04.24 with a price of €100.48. The BUY prediction by JPMorgan_Chase___Co_ for Abbott Laboratories closed nearly unchanged. JPMorgan_Chase___Co_ has a follow-up prediction for Abbott Laboratories where he still thinks Abbott Laboratories is a Buy. A total of €1.96 was paid as dividends for this prediction. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Abbott Laboratories | 1.103% | 1.103% | -17.059% | -9.441% |
| iShares Core DAX® | 2.591% | 2.691% | 6.411% | 53.612% |
| iShares Nasdaq 100 | -0.915% | -7.368% | 20.651% | 72.782% |
| iShares Nikkei 225® | 0.145% | -10.196% | 46.169% | 62.432% |
| iShares S&P 500 | -0.367% | -0.833% | 18.019% | 60.744% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at JPMorgan Chase & Co. from $118.00 to $122.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€80.40
17.04.26
17.04.26
€93.41
17.04.27
17.04.27
14.05%
31.07.26
31.07.26
Stopped prediction by JPMorgan_Chase___Co_ for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€87.74
17.07.26
17.07.26
€104.90
17.07.27
17.07.27
4.51%
31.07.26
31.07.26